<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tavares V</submitter><funding>North Portugal Regional Operational Programme</funding><funding>European Union</funding><funding>Fundação para a Ciência e Tecnologia (FCT)</funding><funding>Portuguese League Against Cancer - Northern Branch (LPCC- NRN)</funding><funding>IPO-Porto Research Center</funding><pagination>663-678</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12149255</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>58(5)</volume><pubmed_abstract>Colorectal cancer (CRC) is the second leading cause of malignancy-related death worldwide, representing a significant health concern. Understanding the disease pathogenesis and identifying potential prognostic biomarkers is critical for improving patients' clinical outcomes. Haemostatic components implicated in cancer-associated thrombosis (CAT) seem to favour CRC progression. As such, genetic markers of thrombophilia might be potential prognostic biomarkers among patients with this malignant disease. To offer perspectives, a retrospective cohort study with 204 CRC patients was conducted to investigate the impact of seven germline haemostatic gene determinants on patient prognosis. A sex-stratified analysis was performed as the variants seem to have a distinct influence depending on the pa</pubmed_abstract><journal>Journal of thrombosis and thrombolysis</journal><pubmed_title>Genetic markers of thrombophilia as predictors of outcome in colorectal cancer.</pubmed_title><pmcid>PMC12149255</pmcid><funding_grant_id>NORTE-01-0247-FEDER-033399</funding_grant_id><funding_grant_id>CI-IPO-21-2015</funding_grant_id><funding_grant_id>CI-IPOP-BI-99/2018 - BIL1</funding_grant_id><funding_grant_id>CI-IPOP-BI-99/2018 - BIL2</funding_grant_id><funding_grant_id>2020.08969.BD; https://doi.org/10.54499/2020.08969.BD</funding_grant_id><funding_grant_id>UI/BD/151488/2021</funding_grant_id><funding_grant_id>LPCC-NRN2025-VT</funding_grant_id><funding_grant_id>UIDB/00776/2020-3</funding_grant_id><funding_grant_id>101095359</funding_grant_id><pubmed_authors>Dinis-Ribeiro M</pubmed_authors><pubmed_authors>Medeiros R</pubmed_authors><pubmed_authors>Pereira D</pubmed_authors><pubmed_authors>Lopes C</pubmed_authors><pubmed_authors>Pinelas S</pubmed_authors><pubmed_authors>Pereira C</pubmed_authors><pubmed_authors>Farinha M</pubmed_authors><pubmed_authors>Costa J</pubmed_authors><pubmed_authors>Vilas-Boas MI</pubmed_authors><pubmed_authors>Macedo-Silva C</pubmed_authors><pubmed_authors>Assis J</pubmed_authors><pubmed_authors>Tavares V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genetic markers of thrombophilia as predictors of outcome in colorectal cancer.</name><description>Colorectal cancer (CRC) is the second leading cause of malignancy-related death worldwide, representing a significant health concern. Understanding the disease pathogenesis and identifying potential prognostic biomarkers is critical for improving patients' clinical outcomes. Haemostatic components implicated in cancer-associated thrombosis (CAT) seem to favour CRC progression. As such, genetic markers of thrombophilia might be potential prognostic biomarkers among patients with this malignant disease. To offer perspectives, a retrospective cohort study with 204 CRC patients was conducted to investigate the impact of seven germline haemostatic gene determinants on patient prognosis. A sex-stratified analysis was performed as the variants seem to have a distinct influence depending on the pa</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jun</publication><modification>2026-06-03T06:34:15.563Z</modification><creation>2026-04-25T03:20:39.362Z</creation></dates><accession>S-EPMC12149255</accession><cross_references><pubmed>40425987</pubmed><doi>10.1007/s11239-025-03106-1</doi></cross_references></HashMap>